Mackay Base Hospital

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Chronic kidney disease1 trial
• Colorectal cancer1 trial

Phase

• Phase 32 trials
• Phase 41 trial

Status

• Recruiting2 trials
• Terminated1 trial

Lead sponsor

• Eli Lilly and Company1 trial
• Peter MacCallum Cancer Centre, Australia1 trial
• University of Sydney1 trial

Running trials

• Recruiting

  A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  NCT06119581· Phase 3· Eli Lilly and Company· Source

  Contact: Nimisha Kumari (principal investigator)

• Recruiting

  Randomised Evaluation of Sodium Dialysate Levels on Vascular Events

  NCT02823821· Phase 4· University of Sydney· Source

  Contact: Grace Balicki

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease1 recruiting
• Lung cancer1 recruiting

Closed trials

• Terminated

  Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: the VAPOR-C Trial

  NCT04316013· Phase 3· Peter MacCallum Cancer Centre, Australia· Source